Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis. // Mayo Clinic Proceedings: Innovations, Quality & Outcomes. – URL: https://www.sciencedirect.com/science/article/pii/S254245482600072X?dgcid=rss_sd_all
Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. https://www.sciencedirect.com/science/article/pii/S254245482600072X?dgcid=rss_sd_all
“Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis.” Mayo Clinic Proceedings: Innovations, Quality & Outcomes.
@article{article57765,
title = {Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis},
journal = {Mayo Clinic Proceedings: Innovations, Quality \& Outcomes},
url = {https://www.sciencedirect.com/science/article/pii/S254245482600072X?dgcid=rss_sd_all}
}